Cancer cells may employ several immune escape mechanisms, including inadequate presentation of tumor neoantigens, secretion of inhibitory chemokines or cytokines (e.g., TGF-β, IL-10), mutations that make molecules unrecognizable by the immune system, and recruitment of suppressive cells (e.g., Treg, MDSC) (27). Here, TGFB1 is linked to neoplasm.